| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0008 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.092 | 0.006 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.098 | 0.007 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.089 | 0.007 |